What role does CYP1A2 play in Blutzucker?

CYP1A2 is a cytochrome P450 enzyme primarily involved in drug and caffeine metabolism. Its direct role in blood sugar (glucose) regulation is not established. Mechanistic studies suggest that caffeine, metabolized by CYP1A2, can transiently affect insulin sensitivity, but this is indirect and not clinically meaningful. Genetic variants in CYP1A2 (e.g., *1F) influence caffeine clearance rate, which may modulate the metabolic effects of caffeine consumption, but evidence linking CYP1A2 genotype to fasting glucose or diabetes risk is weak and inconsistent. Therefore, CYP1A2 testing is not recommended for blood sugar management. Evidence: mechanistic/unclear. Caveat: No validated clinical utility for glucose control.